Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

641
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

807
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
807
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

1.2K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

2.9K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antihypertensive Combinations Modify Cardiovascular Risk Factor Importance: A Machine Learning Analysis of the ACCOMPLISH Trial.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same author

Mobile Health Unit Outreach to Socially Disadvantaged Urban Communities Detects Uncontrolled Cardiometabolic Risk Factors.

Journal of the American Heart Association·2026
Same author

Increased Density of Mobile Health Unit Encounters Among Primary Care Health Professional Shortage Areas.

International journal of environmental research and public health·2026
Same author

Screening for Chronic Kidney Disease by Mobile Health Unit Outreach.

JAMA network open·2026
Same author

Artificial Intelligence-powered tiered early warning framework addressing high false alarm rates for in-hospital mortality prediction.

NPJ digital medicine·2026
Same author

Association of Socioeconomic Position with Incident Hypertension Hospitalization and Blood Pressure Control among Participants in the Coronary Artery Risk Development in Young Adults Study.

American journal of hypertension·2025

Related Experiment Video

Updated: May 6, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.1K

Acute Heart Failure Treatment.

Phillip D Levy1, Abdel Bellou

  • 1Associate Professor of Emergency Medicine, Assistant Director of Clinical Research, Cardiovascular Research Institute, Associate Director of Clinical Research, Department of Emergency Medicine, Wayne State University School of Medicine, 4201 St. Antoine; UHC - 6G, Detroit, MI 48201, Office: +1 313 993 8558.

Current Emergency and Hospital Medicine Reports
|November 14, 2013
PubMed
Summary
This summary is machine-generated.

Acute heart failure patients often experience dyspnea. Management is shifting from solely diuresis to a nuanced approach considering patient profiles and cardiac dysfunction for effective respiratory symptom relief.

Keywords:
Acute heart failureadenosine receptor antagonistsafterloadangiotensin converting enzyme (ACE) inhibitorsbi-level positive airway pressure (BiPAP)bumetanidecalcium channel blockersclinical profilecongestionconivaptancontinuous positive airway pressure (CPAP)digoxindobutaminedyspneafurosemideinotropelixivaptanloop diureticmilrinonenesiritidenitroglycerinnitrovasodilatorsnon-invasive positive airway pressure ventilation (NIPPV)preloadpump failurerelaxintolvaptantorsemideultrafiltrationvasopressin antagoists

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

28.4K
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

6.2K

Related Experiment Videos

Last Updated: May 6, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.1K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

28.4K
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

6.2K

Area of Science:

  • Cardiology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Dyspnea is a primary symptom in acute heart failure.
  • Conventional treatment often overemphasizes fluid overload and diuresis.

Purpose of the Study:

  • To explore evolving management strategies for acute heart failure beyond diuresis.
  • To highlight the importance of understanding patient profiles and therapeutic options for stabilization.

Main Methods:

  • Review of current literature on acute heart failure management.
  • Analysis of treatment paradigms focusing on complex cardiac dysfunction and precipitants.

Main Results:

  • Not all acute heart failure patients present with fluid overload.
  • Management requires a multifaceted approach addressing cardiac dysfunction and precipitants.

Conclusions:

  • Effective treatment necessitates understanding diverse patient profiles and employing targeted therapies.
  • Key principles include ventilatory support, volume reduction, and hemodynamic improvement to reduce work of breathing and harm.